Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Anti-Cancer Drugs|May 31, 2008
A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patientsPatricia Validire, Christophe Fermé, Pauline Brice, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 6, 2010
Methotrexate Reduces the Incidence of Severe Acute Graft-versus-Host Disease without Increasing the Risk of Relapse after Reduced-Intensity Allogeneic Stem Cell Transplantation from Unrelated DonorsStéphane Vigouroux, Reza Tabrizi, Cyril Melot, et al.
Annals of Hematology|October 7, 2021
Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA studyAlexandra-Cristina Paunescu, Christiane Bergman Copie, Sandra Malak, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 6, 2018
Interim PET Response-adapted Strategy in Untreated Advanced Stage Hodgkin Lymphoma: Results of GOELAMS LH 2007 Phase 2 Multicentric TrialSylvain Carras, Benjamin Dubois, Delphine Senecal, et al.
Haematologica|May 15, 2012
Intensive chemotherapy with thiotepa, busulfan and cyclophosphamide and hematopoietic stem cell rescue in relapsed or refractory primary central nervous system lymphoma and intraocular lymphoma: a retrospective study of 79 casesCarole Soussain, Sylvain Choquet, Emmanuelle Fourme, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Obinutuzumab (GA101) monotherapy in relapsed/refractory diffuse large b-cell lymphoma or mantle-cell lymphoma: results from the phase II GAUGUIN studyFranck Andre Morschhauser, Guillaume Cartron, Catherine Thieblemont, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 18, 2011
(90)Y ibritumomab tiuxetan (Zevalin) combined with BEAM (Z -BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory low-grade CD20-positive B-cell lymphoma. A GELA phase II prospective studyDidier Decaudin, Nicolas Mounier, Hervé Tilly, et al.
Bulletin Du Cancer|November 28, 2017
[Allogeneic haematopoietic cell transplantation for indolent lymphomas: Guidelines from the Francophone Society Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Jordan Gauthier, Sylvain Chantepie, Krimo Bouabdallah, et al.
Bulletin Du Cancer|November 28, 2017
[Allogeneic haematopoietic cell transplantation for diffuse large B cell lymphoma: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Jordan Gauthier, Sylvain Chantepie, Krimo Bouabdallah, et al.
Bulletin Du Cancer|November 25, 2017
[Use of alternative donors for allogeneic haematopoietic cell transplantation in lymphoid neoplasms: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Jordan Gauthier, Sylvain Chantepie, Krimo Bouabdallah, et al.
Pageof 10